scholarly journals Affinity screening and analysis of active components interacted with cancer cells at simulating the <italic>in vivo</italic> micro-environment from traditional Chinese medicines

2014 ◽  
Vol 44 (3) ◽  
pp. 366-372
Author(s):  
ZhiQi ZHANG ◽  
XiaoNi QI ◽  
ZhaoLi MOU ◽  
Jing ZHANG
Keyword(s):  
Cancer Cells ◽  
Traditional Chinese Medicines ◽  
Active Components ◽  
Chinese Medicines

scholarly journals Comparative effects of traditional Chinese and Western migraine medicines in an animal model of nociceptive trigeminovascular activation

Cephalalgia ◽  
2017 ◽  
Vol 38 (7) ◽  
pp. 1215-1224 ◽  
Author(s):  
Yonglie Zhao ◽  
Margarida Martins-Oliveira ◽  
Simon Akerman ◽  
Peter J Goadsby
Keyword(s):  
Clinical Trial Data ◽  
Preventive Treatment ◽  
Pharmacokinetic Profile ◽  
Neuronal Firing ◽  
Migraine Treatment ◽  
Traditional Chinese Medicines ◽  
Chinese Medicines ◽  
Potential Efficacy ◽  
Trigeminal Activation

Background Migraine is a highly prevalent and disabling disorder of the brain with limited therapeutic options, particularly for preventive treatment. There is a need to identify novel targets and test their potential efficacy in relevant preclinical migraine models. Traditional Chinese medicines have been used for millennia and may offer avenues for exploration. Methods We evaluated two traditional Chinese medicines, gastrodin and ligustrazine, and compared them to two Western approaches with propranolol and levetiracetam, one effective and one ineffective, in an established in vivo rodent model of nociceptive durovascular trigeminal activation. Results Intravenous gastrodin (30 and 100 mg/kg) significantly inhibited nociceptive dural-evoked neuronal firing in the trigeminocervical complex. Ligustrazine (10 mg/kg) and propranolol (3 mg/kg) also significantly inhibited dural-evoked trigeminocervical complex responses, although the timing of responses of ligustrazine does not match its pharmacokinetic profile. Levetiracetam had no effects on trigeminovascular responses. Conclusion Our data suggest gastrodin has potential as an anti-migraine treatment, whereas ligustrazine seems less promising. Interestingly, in line with clinical trial data, propranolol was effective and levetiracetam not. Exploration of the mechanisms and modelling effects of Chinese traditional therapies offers novel route for drug discovery in migraine.

scholarly journals Targeting Cancer Metabolism to Resensitize Chemotherapy: Potential Development of Cancer Chemosensitizers from Traditional Chinese Medicines

Cancers ◽  
2020 ◽  
Vol 12 (2) ◽  
pp. 404 ◽  
Author(s):  
Guo ◽  
Tan ◽  
Chen ◽  
Wang ◽  
Feng
Keyword(s):  
Chinese Medicine ◽  
Cancer Therapy ◽  
Traditional Chinese Medicine ◽  
Cancer Cells ◽  
Metabolic Pathways ◽  
Cancer Metabolism ◽  
Metabolic Reprogramming ◽  
Traditional Chinese Medicines ◽  
Chinese Medicines ◽  
Incidence And Mortality

Cancer is a common and complex disease with high incidence and mortality rates, which causes a severe public health problem worldwide. As one of the standard therapeutic approaches for cancer therapy, the prognosis and outcome of chemotherapy are still far from satisfactory due to the severe side effects and increasingly acquired resistance. The development of novel and effective treatment strategies to overcome chemoresistance is urgent for cancer therapy. Metabolic reprogramming is one of the hallmarks of cancer. Cancer cells could rewire metabolic pathways to facilitate tumorigenesis, tumor progression, and metastasis, as well as chemoresistance. The metabolic reprogramming may serve as a promising therapeutic strategy and rekindle the research enthusiasm for overcoming chemoresistance. This review focuses on emerging mechanisms underlying rewired metabolic pathways for cancer chemoresistance in terms of glucose and energy, lipid, amino acid, and nucleotide metabolisms, as well as other related metabolisms. In particular, we highlight the potential of traditional Chinese medicine as a chemosensitizer for cancer chemotherapy from the metabolic perspective. The perspectives of metabolic targeting to chemoresistance are also discussed. In conclusion, the elucidation of the underlying metabolic reprogramming mechanisms by which cancer cells develop chemoresistance and traditional Chinese medicines resensitize chemotherapy would provide us a new insight into developing promising therapeutics and scientific evidence for clinical use of traditional Chinese medicine as a chemosensitizer for cancer therapy.

Chemical Constituents, Quality Control, and Bioactivity of Epimedii Folium (Yinyanghuo)

2015 ◽  
Vol 43 (05) ◽  
pp. 783-834 ◽  
Author(s):  
Xiao-Jia Chen ◽  
Zheng-Hai Tang ◽  
Xi-Wen Li ◽  
Cai-Xiang Xie ◽  
Jin-Jian Lu ◽  
...  
Keyword(s):  
Quality Control ◽  
Nervous System ◽  
Cardiovascular Diseases ◽  
Bone Formation ◽  
Biological Activities ◽  
Chemical Constituents ◽  
Traditional Chinese Medicines ◽  
Active Components ◽  
Chinese Medicines ◽  
Anticancer Effects

Epimedii Folium (Yinyanghuo in Chinese) is one of the most commonly used traditional Chinese medicines. Its main active components are flavonoids, which exhibit multiple biological activities, such as promotion of bone formation and sexual function, protection of the nervous system, and prevention of cardiovascular diseases. Flavonoids also show anti-inflammatory and anticancer effects. Various effective methods, including genetic and chemical approaches, have been developed for the quality control of Yinyanghuo. In this review, the studies conducted in the last decade about the chemical constituents, quality control, and bioactivity of Yinyanghuo are summarized and discussed.

scholarly journals Application of Traditional Chinese Medicines in Postoperative Abdominal Adhesion

2020 ◽  
Vol 2020 ◽  
pp. 1-9 ◽  
Author(s):  
Fuling Wu ◽  
Wenqin Liu ◽  
Haixing Feng ◽  
Li Long ◽  
Lianbing Hou ◽  
...  
Keyword(s):  
Acupuncture Treatment ◽  
Modern Medicine ◽  
Clinical Applications ◽  
Therapeutic Effects ◽  
Traditional Chinese Medicines ◽  
Chinese Medicinal Herbs ◽  
Active Components ◽  
Chinese Medicines ◽  
Abdominal Adhesion ◽  
New Strategies

Adhesion is a frequent complication after abdominal surgery. Although various methods have been applied to prevent and treat postoperative abdominal adhesion (PAA), few modern drugs designed for clinical applications have reached the expected preventive or therapeutic effect so far. There is an imperative to develop some new strategies for the treatment of PAA. Traditional Chinese medicine (TCM) has been widely practiced for thousands of years and played an indispensable role in the prevention and treatment of diseases. Modern medicine researchers have accepted the therapeutic effects of many active components derived from Chinese medicinal herbs. The review stresses the most commonly used TCM treatment, including Chinese medicinal herbals and monomers, TCM formulas, and acupuncture treatment.

Sign in / Sign up

Export Citation Format

Share Document